Camp4 Therapeutics Poration Stock Analysis
| CAMP Stock | USD 1.69 0.02 1.20% |
CAMP4 THERAPEUTICS PORATION is overvalued with Real Value of 1.57 and Target Price of 19.91. The main objective of CAMP4 THERAPEUTICS stock analysis is to determine its intrinsic value, which is an estimate of what CAMP4 THERAPEUTICS PORATION is worth, separate from its market price. There are two main types of CAMP4 THERAPEUTICS's stock analysis: fundamental analysis and technical analysis.
The CAMP4 THERAPEUTICS stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. CAMP4 THERAPEUTICS is usually not traded on Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday. CAMP4 Stock trading window is adjusted to America/New York timezone.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CAMP4 THERAPEUTICS PORATION. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. CAMP4 Stock Analysis Notes
About 35.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 0.08. CAMP4 THERAPEUTICS recorded a loss per share of 2.64. The entity had not issued any dividends in recent years. The firm had 1:23 split on the 2nd of February 2024. CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company was incorporated in 1981 and is headquartered in Irvine, California. CalAmp Corp operates under Communication Equipment classification in the United States and is traded on NASDAQ Exchange. It employs 887 people. For more info on CAMP4 THERAPEUTICS PORATION please contact Joshua MandelBrehm at 617-651-8867 or go to https://www.camp4tx.com.CAMP4 THERAPEUTICS Investment Alerts
| CAMP4 THERAPEUTICS generated a negative expected return over the last 90 days | |
| CAMP4 THERAPEUTICS has high historical volatility and very poor performance | |
| CAMP4 THERAPEUTICS may become a speculative penny stock | |
| The company reported the previous year's revenue of 652 K. Net Loss for the year was (51.79 M) with loss before overhead, payroll, taxes, and interest of (37.93 M). | |
| CAMP4 THERAPEUTICS PORATION currently holds about 47.72 M in cash with (45.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.29. | |
| Roughly 57.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Digi International Shares Pass Above 200 Day Moving Average - Time to Sell - MarketBeat |
CAMP4 THERAPEUTICS Upcoming and Recent Events
| 25th of April 2024 Upcoming Quarterly Report | View | |
| 8th of July 2024 Next Financial Report | View | |
| 29th of February 2024 Next Fiscal Quarter End | View | |
| 25th of April 2024 Next Fiscal Year End | View | |
| 30th of November 2023 Last Quarter Report | View | |
| 28th of February 2023 Last Financial Announcement | View |
CAMP4 Largest EPS Surprises
Earnings surprises can significantly impact CAMP4 THERAPEUTICS's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-09-22 | 2022-06-30 | -0.03 | -0.02 | 0.01 | 33 | ||
2021-06-24 | 2021-03-31 | 0.07 | 0.08 | 0.01 | 14 | ||
2011-06-30 | 2011-03-31 | 0.01 | 0.02 | 0.01 | 100 |
CAMP4 Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 102.82 M.CAMP4 Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.66) | (0.63) | |
| Return On Capital Employed | (0.77) | (0.73) | |
| Return On Assets | (0.66) | (0.63) | |
| Return On Equity | (0.82) | (0.78) |
Technical Drivers
As of the 24th of July, CAMP4 THERAPEUTICS shows the Mean Deviation of 4.09, variance of 30.19, and Coefficient Of Variation of (5,739). CAMP4 THERAPEUTICS technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the entity's future prices.CAMP4 THERAPEUTICS Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. CAMP4 THERAPEUTICS middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for CAMP4 THERAPEUTICS. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
CAMP4 THERAPEUTICS Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CAMP4 THERAPEUTICS insiders, such as employees or executives, is commonly permitted as long as it does not rely on CAMP4 THERAPEUTICS's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CAMP4 THERAPEUTICS insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
CAMP4 THERAPEUTICS Outstanding Bonds
CAMP4 THERAPEUTICS issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. CAMP4 THERAPEUTICS uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most CAMP4 bonds can be classified according to their maturity, which is the date when CAMP4 THERAPEUTICS PORATION has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
CAMP4 THERAPEUTICS Predictive Daily Indicators
CAMP4 THERAPEUTICS intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of CAMP4 THERAPEUTICS stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
CAMP4 THERAPEUTICS Forecast Models
CAMP4 THERAPEUTICS's time-series forecasting models are one of many CAMP4 THERAPEUTICS's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CAMP4 THERAPEUTICS's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About CAMP4 Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how CAMP4 THERAPEUTICS prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CAMP4 shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as CAMP4 THERAPEUTICS. By using and applying CAMP4 Stock analysis, traders can create a robust methodology for identifying CAMP4 entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (79.43) | (75.46) | |
| Operating Profit Margin | (81.42) | (77.35) | |
| Net Loss | (79.43) | (75.46) | |
| Gross Profit Margin | 0.32 | 0.25 |
Current CAMP4 Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. CAMP4 analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. CAMP4 analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 19.91 | Strong Buy | 5 | Odds |
Most CAMP4 analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand CAMP4 stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of CAMP4 THERAPEUTICS, talking to its executives and customers, or listening to CAMP4 conference calls.
CAMP4 Stock Analysis Indicators
CAMP4 THERAPEUTICS PORATION stock analysis indicators help investors evaluate how CAMP4 THERAPEUTICS stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading CAMP4 THERAPEUTICS shares will generate the highest return on investment. By understating and applying CAMP4 THERAPEUTICS stock analysis, traders can identify CAMP4 THERAPEUTICS position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 40 M | |
| Common Stock Shares Outstanding | 19.5 M | |
| Total Stockholder Equity | 63.1 M | |
| Total Cashflows From Investing Activities | -441 K | |
| Property Plant And Equipment Net | 10.3 M | |
| Cash And Short Term Investments | 64 M | |
| Cash | 64 M | |
| Accounts Payable | 1.2 M | |
| Net Debt | -55.4 M | |
| 50 Day M A | 5.5912 | |
| Total Current Liabilities | 9.6 M | |
| Other Operating Expenses | 53.7 M | |
| Non Current Assets Total | 11.9 M | |
| Non Currrent Assets Other | 1.6 M | |
| Stock Based Compensation | 4 M |
Additional Tools for CAMP4 Stock Analysis
When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.